vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and WILLIS LEASE FINANCE CORP (WLFC). Click either name above to swap in a different company.

WILLIS LEASE FINANCE CORP is the larger business by last-quarter revenue ($193.6M vs $121.8M, roughly 1.6× Core Laboratories Inc.). On growth, WILLIS LEASE FINANCE CORP posted the faster year-over-year revenue change (26.7% vs -1.4%). WILLIS LEASE FINANCE CORP produced more free cash flow last quarter ($66.2M vs $517.0K). Over the past eight quarters, WILLIS LEASE FINANCE CORP's revenue compounded faster (27.5% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Willis Lease Finance Corp is a leading global independent provider of commercial aviation asset solutions. It primarily leases and sells commercial aircraft engines, auxiliary power units and other aviation spare parts, serving airline operators, MRO providers and other aviation industry participants across major global markets.

CLB vs WLFC — Head-to-Head

Bigger by revenue
WLFC
WLFC
1.6× larger
WLFC
$193.6M
$121.8M
CLB
Growing faster (revenue YoY)
WLFC
WLFC
+28.2% gap
WLFC
26.7%
-1.4%
CLB
More free cash flow
WLFC
WLFC
$65.7M more FCF
WLFC
$66.2M
$517.0K
CLB
Faster 2-yr revenue CAGR
WLFC
WLFC
Annualised
WLFC
27.5%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
WLFC
WLFC
Revenue
$121.8M
$193.6M
Net Profit
$5.1M
Gross Margin
Operating Margin
1.5%
7.3%
Net Margin
4.2%
Revenue YoY
-1.4%
26.7%
Net Profit YoY
EPS (diluted)
$0.11
$1.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
WLFC
WLFC
Q1 26
$121.8M
Q4 25
$138.3M
$193.6M
Q3 25
$134.5M
$183.4M
Q2 25
$130.2M
$195.5M
Q1 25
$123.6M
$157.7M
Q4 24
$129.2M
$152.8M
Q3 24
$134.4M
$146.2M
Q2 24
$130.6M
$151.1M
Net Profit
CLB
CLB
WLFC
WLFC
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$14.2M
$24.3M
Q2 25
$10.6M
$60.4M
Q1 25
$-154.0K
$16.9M
Q4 24
$7.4M
Q3 24
$11.7M
$24.1M
Q2 24
$9.0M
$42.6M
Gross Margin
CLB
CLB
WLFC
WLFC
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
WLFC
WLFC
Q1 26
1.5%
Q4 25
11.5%
7.3%
Q3 25
15.6%
20.7%
Q2 25
11.7%
14.5%
Q1 25
3.6%
15.2%
Q4 24
11.0%
19.2%
Q3 24
14.7%
23.0%
Q2 24
12.3%
35.8%
Net Margin
CLB
CLB
WLFC
WLFC
Q1 26
4.2%
Q4 25
3.6%
Q3 25
10.6%
13.3%
Q2 25
8.2%
30.9%
Q1 25
-0.1%
10.7%
Q4 24
5.7%
Q3 24
8.7%
16.5%
Q2 24
6.9%
28.2%
EPS (diluted)
CLB
CLB
WLFC
WLFC
Q1 26
$0.11
Q4 25
$0.11
$1.50
Q3 25
$0.30
$3.25
Q2 25
$0.22
$8.43
Q1 25
$0.00
$2.21
Q4 24
$0.15
$2.76
Q3 24
$0.25
$3.37
Q2 24
$0.19
$6.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
WLFC
WLFC
Cash + ST InvestmentsLiquidity on hand
$22.8M
$16.4M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$275.1M
$662.1M
Total Assets
$587.7M
$3.9B
Debt / EquityLower = less leverage
4.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
WLFC
WLFC
Q1 26
$22.8M
Q4 25
$22.7M
$16.4M
Q3 25
$25.6M
$12.9M
Q2 25
$31.2M
$37.3M
Q1 25
$22.1M
$32.4M
Q4 24
$19.2M
$9.1M
Q3 24
$21.5M
$5.8M
Q2 24
$17.7M
$5.0M
Total Debt
CLB
CLB
WLFC
WLFC
Q1 26
Q4 25
$110.3M
$2.7B
Q3 25
$114.1M
$2.2B
Q2 25
$124.6M
$2.8B
Q1 25
$124.4M
$2.2B
Q4 24
$126.1M
$2.3B
Q3 24
$139.9M
$2.0B
Q2 24
$147.6M
$1.9B
Stockholders' Equity
CLB
CLB
WLFC
WLFC
Q1 26
$275.1M
Q4 25
$266.0M
$662.1M
Q3 25
$271.3M
$650.2M
Q2 25
$261.3M
$617.9M
Q1 25
$253.4M
$565.5M
Q4 24
$246.6M
$549.3M
Q3 24
$250.7M
$517.8M
Q2 24
$240.3M
$492.4M
Total Assets
CLB
CLB
WLFC
WLFC
Q1 26
$587.7M
Q4 25
$584.0M
$3.9B
Q3 25
$591.4M
$3.4B
Q2 25
$602.1M
$3.9B
Q1 25
$591.5M
$3.3B
Q4 24
$585.1M
$3.3B
Q3 24
$600.5M
$3.0B
Q2 24
$597.8M
$2.9B
Debt / Equity
CLB
CLB
WLFC
WLFC
Q1 26
Q4 25
0.41×
4.08×
Q3 25
0.42×
3.44×
Q2 25
0.48×
4.53×
Q1 25
0.49×
3.95×
Q4 24
0.51×
4.12×
Q3 24
0.56×
3.84×
Q2 24
0.61×
3.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
WLFC
WLFC
Operating Cash FlowLast quarter
$4.0M
$74.2M
Free Cash FlowOCF − Capex
$517.0K
$66.2M
FCF MarginFCF / Revenue
0.4%
34.2%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$252.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
WLFC
WLFC
Q1 26
$4.0M
Q4 25
$7.9M
$74.2M
Q3 25
$8.5M
$63.9M
Q2 25
$13.9M
$104.2M
Q1 25
$6.7M
$41.0M
Q4 24
$20.6M
$68.0M
Q3 24
$13.1M
$86.8M
Q2 24
$17.1M
$69.8M
Free Cash Flow
CLB
CLB
WLFC
WLFC
Q1 26
$517.0K
Q4 25
$5.0M
$66.2M
Q3 25
$6.5M
$57.8M
Q2 25
$10.4M
$94.5M
Q1 25
$3.9M
$33.5M
Q4 24
$17.4M
$55.1M
Q3 24
$10.4M
$85.7M
Q2 24
$14.3M
$68.5M
FCF Margin
CLB
CLB
WLFC
WLFC
Q1 26
0.4%
Q4 25
3.6%
34.2%
Q3 25
4.8%
31.5%
Q2 25
8.0%
48.4%
Q1 25
3.1%
21.3%
Q4 24
13.4%
36.1%
Q3 24
7.7%
58.6%
Q2 24
10.9%
45.3%
Capex Intensity
CLB
CLB
WLFC
WLFC
Q1 26
Q4 25
2.1%
4.1%
Q3 25
1.5%
3.3%
Q2 25
2.7%
4.9%
Q1 25
2.3%
4.7%
Q4 24
2.5%
8.4%
Q3 24
2.0%
0.7%
Q2 24
2.2%
0.9%
Cash Conversion
CLB
CLB
WLFC
WLFC
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
2.63×
Q2 25
1.31×
1.73×
Q1 25
2.43×
Q4 24
2.78×
Q3 24
1.12×
3.60×
Q2 24
1.90×
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons